InvestorsHub Logo
Followers 71
Posts 11465
Boards Moderated 0
Alias Born 12/25/2009

Re: None

Tuesday, 04/03/2012 7:42:45 AM

Tuesday, April 03, 2012 7:42:45 AM

Post# of 636
Human Genome (NASDAQ:HGSI) Canaccord Genuity has initiated coverage for Human Genome at Hold. Human Genome Sciences, Inc. is a commercially focused biopharmaceutical company advancing toward the market with three products in late-stage clinical development.

Read more: http://thestockmarketwatch.com/stock-market-news/analyst-ratings/new-analyst-coverage/analysts-initiated-coverage-for-ziop-dndn-fnfg-hmst-hgsi-incy/23514#ixzz1qycZr94A

HGSI